ANGO News and Press, AngioDynamics Inc.

2024-07-17 15:16:10 ET Summary AngioDynamics stock reacted positively to fiscal Q4 results, up over 25% in a day, as the company saw 8% sequential revenue growth and 14% growth from the Med Tech portfolio. Auryon and NanoKnife generated double-digit year-over-year growth, while Al...

2024-07-16 10:35:27 ET AngioDynamics Inc. (ANGO) Q4 2024 Earnings Conference Call July 16, 2024 08:00 AM ET Company Participants Jim Clemmer - President & CEO Stephen Trowbridge - EVP & CFO Conference Call Participants John Young - Canaccord Genui...

Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...

2024-07-16 06:36:57 ET More on AngioDynamics AngioDynamics: A Story To Monitor AngioDynamics receives CE Mark approval in Europe for AlphaVac F18⁸⁵ System Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDyn...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...

2024-07-15 11:33:27 ET More on AngioDynamics AngioDynamics: A Story To Monitor AngioDynamics receives CE Mark approval in Europe for AlphaVac F18⁸⁵ System Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDyn...

AZZ Inc. (AZZ) is expected to report $1.31 for Q1 2025 Express Inc. (EXPRQ) is expected to report for Q1 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2025 Altamira Therapeutics Ltd. (CYTO) is expected to report for Q1 2024 Bassett Furniture Industries Incorporated (...

2024-07-09 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results...

2024-05-22 05:07:36 ET More on AngioDynamics AngioDynamics: A Story To Monitor A Leaner AngioDynamics Is A High-Risk Execution-Driven Story AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript AngioDynamics upgraded at Oppenheimer on pipeline progress ...